Patricia A. Hametz
Dr. Hametz's clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.
Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families.
<p>Patricia A. Hametz, MD, MPH, is Chief of the Division of Pediatric Hospital Medicine at Children’s Hospital at Montefiore Einstein (CHAM). As Chief, she oversees the care of children admitted to the general pediatrics service, consultation service and co-management of patients on the pediatric surgery and surgical subspecialty services. She is also an Attending Physician at CHAM and an Associate Professor of Pediatrics at Albert Einstein College of Medicine. Her clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.</p><p>Dr. Hametz received her Doctor of Medicine in 1995 from Columbia University College of Physicians and Surgeons in New York. In 2008, she received her Master of Public Health from Columbia University Mailman School of Public Health. Dr. Hametz completed an internship and residency in Pediatrics at Morgan Stanley Children's Hospital of New York from 1995 to 1999 and became Chief Resident in 1998.</p><p>Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families. Her original communications have been published in numerous peer-reviewed journals, as well as invited publications. She has been an invited speaker to regional and local presentations.</p><p>Dr. Hametz has been recognized as an outstanding teacher, was nominated for the Attending Teacher of the Year Award several times and also won the Pediatric Residency Appreciation Award in 2015. Dr. Hametz is board certified by the American Board of Pediatrics and is a Resident Member of the American Academy of Pediatrics.</p>
Jonathan M. Gursky
Dr. Gursky focuses on the various needs of epilepsy patients including issues related to medication management and driving.
Dr. Gursky's research focuses on seizure triggers in addition to seizure prediction and analysis. He is involved in various clinical trials investigating new potential therapies for epilepsy.
<p>Jonathan M. Gursky, MD, is an Attending Physician at Montefiore and Assistant Professor of Neurology at our Albert Einstein College of Medicine. His clinical focus is on the diagnosis and treatment of adults and adolescents with epilepsy and seizure disorders.</p><p>After earning his Bachelor of Science at Cornell University in 2010, Dr. Gursky attended the New York University School of Medicine, where he received his Doctor of Medicine in 2014. He began his postgraduate training in 2014 with a year-long internship in internal medicine at Icahn School of Medicine at Mount Sinai. He continued his training at this institution and completed a residency in neurology in 2018, becoming Chief Resident in his final year. In 2019, Dr. Gursky completed a fellowship in clinical neurophysiology at Montefiore.</p><p>Expanding on his clinical focus, Dr. Gursky’s research examines the interactions between epilepsy with various neurological and general medical disorders. His findings have been published in peer-reviewed journals and articles and have been shared at national lectures and presentations.</p><p>Dr. Gursky holds additional clinical interests in the effects of epilepsy on mental and behavioral health.</p><p>Dr. Gursky is a member of the American Academy of Neurology, the American Clinical Neurophysiology Society and the American Epilepsy Society and is board certified by the American Board of Psychiatry and Neurology. </p>
Elissa B. Gross
Karen R. Ballaban-Gil
<p>Dr. Karen Ballaban-Gil is Professor of Neurology and Pediatrics, the Director of the Child Neurology Residency Training Program and Director of Outpatient Child Neurology Services at the Albert Einstein College of Medicine. She graduated Magna Cum Laude from Union College and Cum Laude from Albany Medical College, in the 6 year combined B.S- M.D. program. Dr. Ballaban-Gil trained in general pediatrics at The Johns Hopkins Hospital, and trained in child neurology and clinical neurophysiology and epilepsy at the Albert Einstein College of Medicine. She received board certifications in pediatrics, neurology with special competence in child neurology , clinical neurophysiology and in epilepsy.</p>
<p><br />Dr. Ballaban-Gil has a large clinical practice in child neurology, including the evaluation and treatment of children with epilepsy, headaches, sleep disorders, autism and other developmental disabilities. Her research interests include the relationship between epilepsy and language regression in youngsters with Landau-Kleffner Syndrome, autism, and other developmental disorders of higher cognitive functioning. In addition, she runs the Ketogenic Diet program for the management of intractable epilepsy at the Montefiore Medical Center - Comprehensive Epilepsy Center. Her publications include numerous papers on autism, epilepsy related language disorders, and the Ketogenic Diet.</p>
<p> </p>
<p>Karen Ballaban-Gil, MD, is Director, Pediatric Epilepsy Center and Deputy Director, Division of Child Neurology at the Children’s Hospital at Montefiore Einstein, and Professor, Pediatrics and Neurology at our Albert Einstein College of Medicine. Dr. Ballaban-Gil has a large clinical practice in child neurology, including the evaluation and treatment of children with epilepsy, headaches, sleep disorders, autism and other developmental disabilities.</p><p>After receiving her Bachelor of Science at Union College in 1984, Dr. Ballaban-Gil earned her Doctor of Medicine in 1986 at the Albany Medical College. She began her postgraduate training at Johns Hopkins Hospital, completing two years as an intern and assistant resident in pediatrics before coming to Einstein, where she completed a residency in child neurology, followed by a fellowship in epilepsy and electrophysiology in 1991.</p><p>Dr. Ballaban-Gil’s research interests include the relationship between epilepsy and language regression in youngsters with Landau-Kleffner Syndrome, autism and other developmental disorders of higher cognitive functioning. Her publications include numerous papers on autism, epilepsy related language disorders and the Ketogenic Diet. She has shared her work through national and international meetings, and has been a peer reviewer for a variety of medical journals, including <em>Epilepsia</em> and <em>Cephalgia</em>.</p><p>Dr. Ballaban-Gil is board certified by the American Board of Psychiatry and Neurology in Neurology with special competence in Child Neurology and with Certification in Epilepsy.</p>
Howard Geyer
<p>Dr. Howard Geyer is Director, Division of Movement Disorders, Montefiore, and Assistant Professor, Neurology, Albert Einstein College of Medicine. He received his MD and PhD degrees from the University of Pennsylvania. He was chief resident in Neurology at Montefiore, where he also completed a fellowship in Clinical Neurophysiology. He completed an additional fellowship in Movement Disorders at Beth Israel Medical Center. Dr. Geyer regularly lectures and contributes to book chapters and journal articles on a variety of neurologic topics.</p>
Susan E. Duberstein Coad
<p>Susan Duberstein, MD, is Associate Professor, Child Neurology and Pediatrics at Montefiore Einstein. Dr. Duberstein is an epileptologist with a special interest in complex care. She is the collaborating neurologist for the Linking Individual Needs of Children with Services (LINCS) clinic, which provides a “medical home” and family-centered care for children with chronic illnesses, multiple conditions and medical technologies. She is also the Associate Director of the Neurocutaneous Clinic, serving children with neurofibromatosis, Sturge-Weber, tuberous sclerosis complex and other neurocutaneous conditions.</p><p>After earning her Doctor of Medicine at the State University of New York Downstate Medical Center in 2008, Dr. Duberstein completed her internship and residency in pediatrics at the same institution in 2010. She then came to Montefiore Einstein to continue her medical training, completing her residency in child neurology in 2013 and a fellowship in clinical neurophysiology and electroencephalography (EEG) in 2014.</p><p>Dr. Duberstein's research focuses include retrospective studies on neurofibromatosis and tuberous sclerosis complex. She is also one of the leaders of a research project investigating the clinical outcomes of autoimmune encephalopathies. Her work has been published in numerous peer-reviewed journals, book chapters and abstracts.</p><p>Dr. Duberstein is board certified by the American Board of Psychiatry and Neurology in Neurology with a special qualification in Child Neurology and holds a subspecialty certificate in Epilepsy. She is a member of the American Academy of Neurology, the Child Neurology Society and the American Epilepsy Society. Dr. Duberstein was elected a Fellow of the American Epilepsy Society in 2022.</p>
Aleksandra Jacobs
<p>Aleksandra Djukic, is Associate Professor of Neurology . She completed her neurology residency at the Albert Einstein College of Medicine. She is a diplomate of the American Board of Psychiatry and Neurology.</p>
<p>Dr. Djukic has Ph.D. in neuropsychology and is especially qualified for evaluations and treatment of children with learning disabilities, addressing both cognitive and neurological problems in children with a variety of hereditary neurological diseases and babies with neonatal neurological problems.</p>
<p>Dr. Djukic gained extensive experience following and treating more than 300 children with traumatic brain injuries.</p>
<p>Currently she is <strong>Director of the Center for Rett Syndrome</strong> which is the only Center for Rett syndrome in the Tri-State area.</p>
<p>Dr. Djukic is member of the International Consortium for Rett Syndrome "RettSearch", Leader of the Working group for development of Treatment Quidelines for Rett Syndrome, Grant reviewer for IRSF, member of the International Committee for the research of bio markers in Rett Syndrome and member of the International Committee for the research of the outcome measures in Rett Syndrome.</p>
<p>Dr. Djukic is member of RE-TT (Rett Education -Transforming Teaching) a group which is actively addressing educational issued and provides support to families .</p>
<p>Dr. Djukic is also Director of the Neonatal Neurology service.</p>
<p>She is a member of the New York State Consortium for Krabbe Disease .<br /><br />Dr. Djukic speaks both English and Serbian.</p>
Neuropsychology
The clinical focus is providing care for patients with Rett syndrome. She founded the Tri-State Rett Center at Montefiore in 2008, which provides comprehensive multidisciplinary care to 380 patients with Rett syndrome, and has been awarded a designation of the National Center of Excellence for Rett syndrome in 2021. Dr. Djukic serves on the Medical Advisory Board of the International Rett Syndrome Foundation. She has published about clinical care and worked with other Rett specialists to develop a better understanding of Rett syndrome and develop better outcome measures and biomarkers that can be used in treatment trials. She was the founder of an international Blue Sky Girls event that raised awareness about Rett syndrome.
Her vision to develop the Rett Syndrome Center at Montefiore originated from the optimism brought by the scientific evidence that several major aspects of the phenotype of the disorder could be fully reversed in an animal model, even in its terminal stages. However, we still do not understand well the full phenotype of the human disease inter-relationship between various symptoms, especially those autonomic and behavioral/cognitive. The main research goals of the Rett Syndrome Center, therefore, entail systematic and uniform documentation of the natural history, development of objective outcome measures, and better treatment strategies. These goals complement our endeavor to implement the best clinical practices in the clinical care of our patients.<br /><br />Dr. Djukic has a special interest in neuropsychology and how those with Rett syndrome communicate and excel in their education. She was the first to implement effective eye tracking technology as a method of cognitive assessment in patients with Rett syndrome and objective neurophysiological techniques to assess their language processing. <br /><br />Her current main research interest is related to the development of more effective therapies for individuals with Rett syndrome. She was the Principal investigator in seven clinical trials of Rett syndrome. She has also published about clinical care and worked with other scientists to develop a better understanding of Rett syndrome and develop better outcome measures and biomarkers that can be used in treatment trials.
<p>Djukic, A., Lado, F. A., Shinnar, S., Moshé, S. L., Are early myoclonic encephalopathy (EME) and the Ohtahara Syndrome (EIEE) independent of each other? Epilepsy Research, 70 (2-3S): 68-76 (2006).</p>
<p>Djukic A. Folate responsive neurological disorders, in Press. Pediatric neurology 2007. Review.</p>
<p>Wilson S, Djukic A, Shinnar S, Dharmani C, Rapin I. (2003) Clinical characteristics of language regression in children. Developmental Medicine Child Neurology 45:508-514.</p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"><span style="font-family: Arial; font-size: 11.0pt;">Djukic A.</span><span style="font-family: Arial; font-size: 10.0pt;"> Neurological Abnormalities in newborn , AAP ,Pediatric Primary Care , Chapter 106</span></p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"> </p>
<p style="text-autospace: none; font-family: 'Times New Roman'; font-size: 12.0pt; margin: 0in 0in .0001pt 0in;"><span style="font-family: Arial; font-size: 10.0pt;">Djukic A, Vigevano F, Plouin P, Moshe S.L. Early myoclonic encephalopathy (neonatal myoclonic encephalopathy)</span><span style="font-family: 'Times New Roman'; font-size: 11.0pt; color: black;">. Epilepsy: a comprehensive textbook, 2 ed. Engel J, Pedley T eds. Lippincot Williams&Wilkins, Philadelphia 2007. Chapter 224.</span></p>
Jennifer G. Davila
Diagnosis and management of children with thrombosis, hemophilia and rare bleeding disorders.
Her primary areas of academic interest include quality improvement efforts to improve thrombosis risk assessment in the pediatric population, specifically elucidating the thrombosis risk in patients with sickle cell disease.
<p>Jennifer G. Davila, MD, is Co-Director, Hemophilia Treatment Center at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Davila focuses on the care of children with bleeding and clotting disorders.</p><p>After obtaining her Bachelor of Science in psychobiology from the State University of New York at Binghamton in 2000, Dr. Davila earned her Doctor of Medicine at Ross University School of Medicine in 2007. She completed her pediatrics internship and residency at the State University of New York Downstate Medical Center in 2010. Dr. Davila continued her medical training at Memorial Sloan Kettering Cancer Center/Weill-Cornell Medical College, completing a pediatric hematology/oncology fellowship in 2013 where she was Chief Fellow in her final year. She also completed a research fellowship at the same institution in 2014.</p><p>Dr. Davila's research focuses on thrombosis prevention in children. She has been primary investigator and co-primary investigator on funded research projects, and has shared her work through numerous peer-reviewed publications and presentations.</p><p>Dr. Davila is board certified by the American Board of Pediatrics in General Pediatrics and Pediatric Hematology Oncology. She is a member of several professional organizations, including the American Society of Hematology, the Hemostasis and Thrombosis Research Society and the American Society of Clinical Oncology, among others. She sits on the board of the American Thrombosis and Hemostasis Network, is co-chair of the Pediatric sub-committee of the Venous Thromboembolism Network of the United States and is a member of the Medical and Scientific Advisory Council of the National Bleeding Disorders Foundation.</p>